Skip to content

GeneDx Holdings

US · WGS #2702 by market cap Listed 1970
68.53 -2.99 -4.18%
Live - 5344 symbols - heartbeat 218s ago · 2026-10-08 08:30
Pre-market 68.00 -0.77%
After-hours 68.53 0.00%
Overnight 68.50 -0.04%
Market cap
2.04B
P/B
8.37
EPS
-0.73
Reader sentiment Are you bullish or bearish on WGS?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
  • Total institutional ownership fell 2.7 percentage points.

Institutional ownership

Held by institutions
106.04% -2.65pp
Institutions
279 -3
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund48.19%
Hedge Fund26.34%
VC/PE Fund14.91%
Public Company11.56%
Private Company3.17%
Individual/Insider1.86%
Sovereign Wealth Fund0.92%
Government Pension Fund0.71%
Insurance Company0.16%

Top holders as of 2026-06-30

Corvex Management LP 16.04% · 4.78M sh
Casdin Capital, LLC 12.43% · 3.71M sh
BlackRock 5.72% · 1.71M sh
The Goldman Sachs Group, Inc. 5.48% · 1.63M sh
ARK Investment Management LLC 5.30% · 1.58M sh
William Blair Investment Management, LLC 4.78% · 1.42M sh
Vanguard Capital Management, LLC 3.46% · 1.03M sh
Morgan Stanley 3.29% · 980.52K sh
Citadel Advisors LLC 2.90% · 865.46K sh
First Light Asset Management, LLC 2.63% · 783.92K sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 34 buys · 16 sells

NameRoleStake
Corvex Management LP -- 16.04%
Casdin Capital, LLC -- 12.43%
Joshua Ruch Independent Director 0.52%
Jason Ryan Executive Chair of the Board 0.40%
Katherine Stueland Chief Executive Officer 0.39%
Richard Pfenniger Director 0.15%
Kevin Feeley Senior VP of Operations & CFO 0.15%
Emily Leproust Independent Director 0.08%
Eli Casdin Independent Director 0.08%
Keith Meister Independent Director 0.08%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-16 Thomas Fuchs Director Derivative Exercise and Retained +1,146 --
2026-09-15 Katherine Stueland Chief Executive Officer Derivative Exercise and Sale -10,501 $94.26–99.00
2026-09-15 Katherine Stueland Chief Executive Officer Derivative Exercise and Retained +8,249 --
2026-09-15 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Sale -3,728 $94.26–99.00
2026-09-15 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Retained +3,469 --
2026-09-08 Katherine Stueland Chief Executive Officer Derivative Exercise and Sale -3,692 $84.22
2026-09-08 Katherine Stueland Chief Executive Officer Derivative Exercise and Retained +2,855 --
2026-09-08 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Sale -1,285 $84.22
2026-09-08 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Retained +1,177 --
2026-08-31 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Sale -372 $83.84
2026-08-31 Kevin Feeley Senior VP of Operations & CFO Derivative Exercise and Retained +345 --
2026-06-28 Mark Gardner President Other Derivative Acquisition +35,441 --
2026-06-17 Rho Capital Partners, Inc. -- Other Derivative Acquisition +4,248 --
2026-06-17 Rho Capital Partners, Inc. -- Derivative Exercise and Retained +3,576 --
2026-06-17 Richard Pfenniger Director Other Derivative Acquisition +4,248 --
2026-06-17 Richard Pfenniger Director Derivative Exercise and Retained +3,576 --
2026-06-17 Keith Meister Independent Director Other Derivative Acquisition +4,248 --
2026-06-17 Keith Meister Independent Director Derivative Exercise and Retained +3,576 --
2026-06-17 Eli Casdin Independent Director Other Derivative Acquisition +4,248 --
2026-06-17 Eli Casdin Independent Director Derivative Exercise and Retained +3,576 --

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 08:30:23 · For reference only, not investment advice and not tailored to your situation.